TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 24 05 2019
accepted: 19 07 2019
pubmed: 16 8 2019
medline: 16 5 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

Phosphoantigen-reactive Vγ9Vδ2 T cells represent the main innate human γδ T cell subset and dominate the fetal and adult peripheral blood γδ T cell repertoire. It has been hypothesized that adult blood Vγ9Vδ2 T cells find their origin in the fetus like it is established for mouse innate γδ T cells. To address this issue, we analyzed the CDR3 of the TCR of human blood and thymic Vγ9Vδ2 T cells from fetal until adult life. We first identified key differences in the CDR3 repertoire of fetal and adult blood Vγ9Vδ2 T cells, including in CDR3 features important for phosphoantigen reactivity. Next, we showed that most of these key adult CDR3 features were already present in the postnatal thymus and were further enhanced upon selection in vitro by the microbial-derived phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate. Finally, we demonstrated that the generation of a fetal-type or adult-type Vγ9Vδ2 CDR3 repertoire is determined by the fetal and postnatal nature of the hematopoietic stem and precursor cell. Thus, our data indicate that fetal blood Vγ9Vδ2 T cells find their origin in the fetal thymus whereas adult blood Vγ9Vδ2 T cells are generated to a large degree independently after birth.

Identifiants

pubmed: 31413106
pii: jimmunol.1900592
doi: 10.4049/jimmunol.1900592
doi:

Substances chimiques

Receptors, Antigen, T-Cell, gamma-delta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1479

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Auteurs

Maria Papadopoulou (M)

Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Institute for Medical Immunology, Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium.

Paola Tieppo (P)

Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Institute for Medical Immunology, Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium.

Naomi McGovern (N)

Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.

Françoise Gosselin (F)

Department of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.

Jerry K Y Chan (JKY)

Department of Reproductive Medicine, KK Women's and Children's Hospital, 229899 Singapore.
Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, 119228 Singapore.
Obstetrics and Gynecology Academic Clinical Program, Duke-NUS, Duke-NUS Medical School, 169857 Singapore.

Glenn Goetgeluk (G)

Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, 9000 Ghent, Belgium.

Nicolas Dauby (N)

Institute for Medical Immunology, Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium.
Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.

Alexandra Cogan (A)

Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium; and.

Catherine Donner (C)

Department of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.

Florent Ginhoux (F)

Singapore Immunology Network, Agency for Science, Technology and Research, 138648 Singapore.

Bart Vandekerckhove (B)

Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, 9000 Ghent, Belgium.

David Vermijlen (D)

Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium; dvermijl@ulb.ac.be.
Institute for Medical Immunology, Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH